Soheila Rahgozar Selected Research

Drug Therapy (Chemotherapy)

10/2022	Puzzling out iron complications in cancer drug resistance.
1/2021	Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin.
1/2020	Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity.
8/2019	Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells.
4/2019	Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
6/2016	Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.
5/2015	mRNA overexpression of BAALC: A novel prognostic factor for pediatric acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Soheila Rahgozar Research Topics

Disease

24	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 01/2014
11	Neoplasms (Cancer) 10/2023 - 05/2015
7	Residual Neoplasm 06/2020 - 01/2014
5	Leukemia 10/2023 - 01/2019
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 06/2012 - 02/2007
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2023 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2017
1	Iron Overload 10/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Cognitive Dysfunction 01/2020
1	Hematologic Diseases (Blood Diseases) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Hyperthermia 12/2018
1	Carcinoma (Carcinomatosis) 05/2018
1	Pre-Eclampsia (Preeclampsia) 01/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2013

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2015
6	Messenger RNA (mRNA)IBA 06/2020 - 01/2014
5	ginger extractIBA 10/2023 - 08/2019
5	Proteins (Proteins, Gene)FDA Link 05/2023 - 09/2016
5	MicroRNAs (MicroRNA)IBA 06/2020 - 06/2016
4	Methotrexate (Mexate)FDA LinkGeneric 07/2023 - 09/2016
4	IronIBA 10/2022 - 01/2017
3	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 01/2020
3	beta 2-Glycoprotein I (Apolipoprotein H)IBA 06/2012 - 02/2007
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2021 - 04/2019
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 11/2020 - 01/2020
2	QuercetinIBA 01/2020 - 01/2019
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2018 - 05/2018
2	polyglycerolIBA 12/2018 - 05/2018
2	AutoantigensIBA 06/2012 - 04/2008
1	Polysaccharides (Glycans)IBA 07/2023
1	polyacrylamideIBA 05/2023
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 05/2023
1	RG7388IBA 01/2023
1	Chelating AgentsIBA 10/2022
1	CarcinogensIBA 10/2022
1	ElementsIBA 10/2022
1	Competitive Endogenous RNAIBA 02/2021
1	Long Noncoding RNAIBA 02/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	EnzymesIBA 01/2020
1	AntioxidantsIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	FlavonoidsIBA 01/2019
1	Therapeutic UsesIBA 12/2018
1	Adenosine Triphosphate (ATP)IBA 07/2017
1	RNA Splice SitesIBA 07/2017
1	CalciumIBA 09/2016
1	Sulfhydryl Compounds (Thiols)IBA 01/2015
1	AngiotensinogenIBA 01/2015
1	multidrug resistance-associated protein 1IBA 01/2014
1	Liver X ReceptorsIBA 01/2013
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2013
1	AutoantibodiesIBA 06/2012
1	AntigensIBA 06/2012

Therapy/Procedure

8	Therapeutics 10/2023 - 01/2014
7	Drug Therapy (Chemotherapy) 10/2022 - 05/2015
1	Aftercare (After-Treatment) 01/2018